Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab + VGF/F-GIV in Relapsed/Refractory CD20+ Lymphomas
NCT00280878Phase 2Completed
- Start
- Jan 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in non-Hodgkin lymphoma (NHL). Started Jan 2006; status: completed.
02
Drugs
rituximab
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00280878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00280878.